Sale!
CLSI POCT14 – Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline, POCT14AE
This guideline provides recommendations to users and manufacturers of point-of-care coagulation testing devices for monitoring heparin and vitamin K antagonist therapy and for the evaluation of hemostasis, as well as to ensure reliable results comparable with those obtained by routine medical laboratory testing.
Product Details
- Edition:
- 2nd
- Published:
- 07/27/2020
- ISBN(s):
- 9781684400874
- Number of Pages:
- 68
- File Size:
- 1 file , 6.8 MB
- Note:
- This product is unavailable in Russia, Belarus
Related products
-
CLSI VET05-R (R2018)
$108.00Add to cartGeneration, Presentation, and Application of Antimicrobial Susceptibility Test Data for Bacteria of Animal Origin; A Report, VET05RE
Published by Publication Date Number of Pages CLSI 09/01/2011 72 -
CLSI QMS21 (R2021)
$108.00Add to cartPurchasing and Inventory Management, 1st Edition, QMS21Ed1E
Published by Publication Date Number of Pages CLSI 11/01/2016 114 -
CLSI VET06
$108.00Add to cartMethods for Antimicrobial Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria Isolated From Animals, 1st Edition, VET06Ed1E
Published by Publication Date Number of Pages CLSI 01/01/2017 114 -
CLSI VET03/VET04-S2
$108.00Add to cartPerformance Standards for Antimicrobial Susceptibility Testing of Bacteria Isolated From Aquatic Animals; Second Informational Supplement,VET03VET04S1E
Published by Publication Date Number of Pages CLSI 09/01/2014 0
